Search Results

Return to List
Results 21–34 of 34
Sort By: Relevance | Date | Title
21.

Well-Woman Visit

Committee Opinion Number 534, August 2012

(Reaffirmed 2016)

Abstract The annual health assessment annual examination is a fundamental part of medical care and is valuable in promoting prevention practices recognizing risk factors for disease identifying medical problems and establishing the clinicianpatient relationship The annual health assessment should ...

August 2012

PDF Format
22.

Lead Screening During Pregnancy and Lactation

Committee Opinion Number 533, August 2012

(Reaffirmed 2016)

Abstract Prenatal lead exposure has known adverse effects on maternal health and infant outcomes across a wide range of maternal blood lead levels Adverse effects of lead exposure are being identified at lower levels of exposure than previously recognized in both children and adults In 2010 the Ce...

August 2012

PDF Format
23.

Placenta Accreta

Committee Opinion Number 529, July 2012

Reaffirmed 2015

ABSTRACT Placenta accreta is a potentially lifethreatening obstetric condition that requires a multidisciplinary approach to management The incidence of placenta accreta has increased and seems to parallel the increasing cesarean delivery rate Women at greatest risk of placenta accreta are those w...

July 2012

PDF Format
24.

Health Care for Lesbians and Bisexual Women

Committee Opinion Number 525, May 2012

(Reaffirmed 2016)

ABSTRACT Lesbians and bisexual women encounter barriers to health care that include concerns about confidentiality and disclosure discriminatory attitudes and treatment limited access to health care and health insurance and often a limited understanding as to what their health risks may be Health ...

May 2012

PDF Format
25.

Intimate Partner Violence

Committee Opinion Number 518, February 2012

ABSTRACT Intimate partner violence IPV is a significant yet preventable public health problem that affects millions of women regardless of age economic status race religion ethnicity sexual orientation or educational background Individuals who are subjected to IPV may have lifelong consequences in...

February 2012

PDF Format
26.

At-Risk Drinking and Alcohol Dependence: Obstetric and Gynecologic Implications

Committee Opinion Number 496, August 2011

(Reaffirmed 2013)

ABSTRACT Compared with men atrisk alcohol use by women has a disproportionate effect on their health and lives including reproductive function and pregnancy outcomes Obstetriciangynecologists have a key role in screening and providing brief intervention patient education and treatment referral for...

August 2011

PDF Format
27.

Update on Carrier Screening for Cystic Fibrosis

Committee Opinion Number 486, April 2011

(Reaffirmed 2014, Replaces No. 325, December 2005)

ABSTRACT In 2001 the American College of Obstetricians and Gynecologists and the American College of Medical Genetics introduced guidelines for prenatal and preconception carrier screening for cystic fibrosis The American College of Obstetricians and Gynecologists Committee on Genetics has updated...

April 2011

PDF Format
28.

Carrier Screening for Fragile X Syndrome

Committee Opinion Number 469, October 2010

(Reaffirmed 2014, Replaces No. 338, June 2006)

ABSTRACT Fragile X syndrome is the most common inherited form of mental retardation The syndrome occurs in approximately 1 in 3600 males and 1 in 40006000 females Approximately 1 in 250 females carry the premutation DNAbased molecular analysis is the preferred method of diagnosis for fragile X syn...

October 2010

PDF Format
29.

Preconception and Prenatal Carrier Screening for Genetic Diseases in Individuals of Eastern European Jewish Descent

Committee Opinion Number 442, October 2009

(Reaffirmed 2014, Replaces No. 298, August 2004)

ABSTRACT Certain autosomal recessive disease conditions are more prevalent in individuals of Eastern European Jewish Ashkenazi descent Previously the American College of Obstetricians and Gynecologists recommended that individuals of Eastern European Jewish ancestry be offered carrier screening fo...

October 2009

PDF Format
30.

The Role of Transvaginal Ultrasonography in the Evaluation of Postmenopausal Bleeding

Committee Opinion Number 440, August 2009

(Reaffirmed 2015)

ABSTRACT The clinical approach to postmenopausal bleeding requires prompt and efficient evaluation to exclude or diagnose carcinoma Women with postmenopausal bleeding may be assessed initially with either endometrial biopsy or transvaginal ultrasonography this initial evaluation does not require p...

August 2009

PDF Format
31.

Human Immunodeficiency Virus

Committee Opinion Number 389, December 2007

(Reaffirmed 2015)

ABSTRACT Because human immunodeficiency virus HIV infection often is detected through prenatal and sexually transmitted disease testing an obstetriciangynecologist may be the first health professional to provide care for a woman infected with HIV Universal testing with patient notification and rig...

December 2007

PDF Format
32.

Patient Testing Ethical Issues in Selection and Counseling

Committee Opinion Number 363, April 2007

(Reaffirmed 2015)

ABSTRACT Recommendations to patients about testing should be based on current medical knowledge a concern for the patients best interests and mutual consultation In addition to establishing a diagnosis testing provides opportunities to educate inform and advise The ethical principles of respect fo...

April 2007

PDF Format
33.

Screening for Tay - Sachs Disease

Committee Opinion Number 318, October 2005

(Reaffirmed 2014, Replaces No. 162, November 1995)

ABSTRACT TaySachs disease TSD is a severe progressive neurologic disease that causes death in early childhood Carrier screening should be offered before pregnancy to individuals and couples at high risk including those of Ashkenazi Jewish FrenchCanadian or Cajun descent and those with a family his...

October 2005

PDF Format
34.

Avoiding Inappropriate Clinical Decisions Based on False-Positive Human Chorionic Gonadotropin Test Results

Committee Opinion Number 278, November 2002

(Reaffirmed 2015)

ABSTRACT Clinically significant falsepositive human chorionic gonadotropin hCG test results are rare However some individuals have circulating factors in their serum eg heterophilic antibodies or nonactive forms of hCG that interact with the hCG antibody and cause unusual or unexpected test result...

November 2002

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998